Qijin Xu, Ph.D. graduated from Peking University and Chinese Academy of Sciences Graduate School. He received his Ph.D. in Molecular, Cellular, and Developmental Biology from the University of Michigan, Ann Arbor. After his post-doctoral training at University of California, Los Angeles, he worked as a research scientist at Cedars-Sinai Medical Center, focusing on brain tumor stem cell research. He was appointed as an assistant professor of neurosurgery at Cedars-Sinai Medical Center in 2011. His main contribution includes discoveries of signaling pathways and molecular mechanisms underlying brain tumor stem cell self-renewal and tumor-initiation, developing technology using bone marrow neural stem cells as a tumor tracking and gene-therapeutics-delivery system, developing novel immunotherapy targeting brain tumor stem cells, studying tumor microenvironment and tumor-stoma interaction, mitochondrial dysfunction and cell metabolism regulation in cancer, etc.
Neural stem cells; brain tumor; cancer stem cells; immunotherapy; neurobiology and neurodegenerative diseases, etc.